A particular case is that of POLE p.Glu396Thrfs*15, identified in four breast cancer–affected women of the same family in absence of additional pathogenic variants in known or candidate hereditary cancer genes (exome sequencing; data not shown). This evidence concerns the gene POLE and cancer.